Skip to main content
RGNX logo

REGENXBIO Inc.

RGNXNASDAQHealthcareBiotechnology

$7.41Today:- (-)1Y −43.00%

As of Oct 29, 2026 close

Market cap
$392.85M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$5.46$16.19
Volume (live)
-
Avg. volume (3M)
1.47M

REGENXBIO Inc. (RGNX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for REGENXBIO Inc. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy
Based on 13 unique analysts
(20 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$21.42
+189.07% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest RGNX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Annabel Samimy
Stifel Nicolaus
BuyMaintains
$42.00
Paul Choi
Goldman Sachs
HoldMaintains
$10.00
Alec Stranahan
BofA Securities
BuyMaintains
$15.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$18.00
Lili (Aurélie) Nsongo
Leerink Partners
BuyMaintains
$19.00
Eliana Merle
Barclays
HoldMaintains
$12.00
Lili (Aurélie) Nsongo
Leerink Partners
BuyMaintains
$19.00
Graig Suvannavejh
Mizuho
BuyInitiates
$22.00
Annabel Samimy
Stifel Nicolaus
BuyReiterates
$42.00
Yi Chen
HC Wainwright
BuyReiterates
$21.00
Alec Stranahan
BofA Securities
BuyReiterates
$15.00
Mara Goldstein
Clear Street
BuyMaintains
$45.00 → $32.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Paul Choi
Goldman Sachs
HoldMaintains
$10.00
Brian Skorney
Baird
BuyMaintains
$32.00 → $29.00
Judah Frommer
Morgan Stanley
BuyMaintains
$18.00
Paul Choi
Goldman Sachs
HoldMaintains
$10.00
Judah Frommer
Morgan Stanley
BuyMaintains
$18.00
Eliana Merle
Barclays
HoldUpgrades
$12.00
Luca Issi
RBC Capital
BuyMaintains
$19.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for RGNX?

The analyst consensus rating for RGNX is Buy, based on the latest ratings from 13 analysts over the last 90 days.

What is the average price target for RGNX?

The average 12-month price target for RGNX is $21.42, representing an upside of 189.1% from the Oct 29, 2026 close of $7.41.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.